Host Markers of Periodontal Diseases: Meta-Analysis of Diagnostic Accuracy Studies
- PMID: 40251882
- DOI: 10.1111/jcpe.14167
Host Markers of Periodontal Diseases: Meta-Analysis of Diagnostic Accuracy Studies
Abstract
Objective: To identify host markers with optimal diagnostic performance for clinical implementation in the diagnosis of periodontal diseases and prediction of future disease progression and/or disease resolution.
Material and methods: Cross-sectional and prospective studies with ≥ 20 participants per group, reporting diagnostic accuracy (e.g., area under the curve [AUC]) of host markers for periodontal diagnosis (focused question 1 [FQ1]), periodontitis progression/relapse (FQ2) or resolution (FQ3) were searched in three electronic databases. Meta-analyses estimating diagnostic accuracy (DA) for individual host markers and for grouped salivary and gingival crevicular fluid (GCF) markers independently were performed whenever two or more studies were identified.
Results: Sixty-one eligible studies were identified, of which 13 were included in meta-analyses for FQ1 (discrimination between health and periodontitis). Matrix metalloproteinase-8 (MMP-8) was the most reported biomarker in both saliva and GCF, with comparable AUC (0.70-0.90), sensitivity (0.49-0.84) and specificity (0.62-0.79) in both sample types. Cytokines had good ability for discrimination of periodontitis/gingivitis versus health, although they were substantially less accurate for periodontitis versus gingivitis. Combinations of cytokines and MMPs tended to increase overall diagnostic accuracy but without significant improvement in the case of periodontitis/gingivitis discrimination. Bone markers were the best performing group of salivary markers (AUC = 0.91) when compared to cytokines (AUC = 0.86) and MMPs (AUC = 0.77). GCF microRNAs (MiRs) were a singly meta-analysed group of biomarkers demonstrating AUC = 0.79.
Conclusion: Reported studies on host periodontal markers exhibit serious limitations regarding clinical and validation standards, being the main cause for lack of progress in clinical implementation of biomarkers in periodontal classification. Disease-specific markers such as bone markers showed better diagnostic performance (from limited number of studies) for the diagnosis of periodontitis when compared to cytokines and MMPs.
Keywords: accuracy; biomarker; diagnosis; periodontitis.
© 2025 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
References
-
- Abdullameer, M. A., and A. A. Abdulkareem. 2023a. “Diagnostic Potential of Salivary Interleukin‐17, RANKL, and OPG to Differentiate Between Periodontal Health and Disease and Discriminate Stable and Unstable Periodontitis: A Case‐Control Study.” Health Science Reports 6: e1103. https://doi.org/10.1002/hsr2.1103.
-
- Abdullameer, M. A., and A. A. Abdulkareem. 2023b. “Salivary Interleukin‐1β as a Biomarker to Differentiate Between Periodontal Health, Gingivitis, and Periodontitis.” Minerva Dental and Oral Science 72: 221–229. https://doi.org/10.23736/S2724‐6329.23.04778‐2.
-
- Afacan, B., H. A. Ilhan, T. Kose, and G. Emingil. 2023. “Gingival Crevicular Fluid Galectin‐3 and Interleukin‐1 Beta Levels in Stage 3 Periodontitis With Grade B and C.” Clinical Oral Investigations 27: 3749–3758. https://doi.org/10.1007/s00784‐023‐04991‐7.
-
- Afacan, B., V. O. Ozturk, G. Emingil, T. Kose, and N. Bostanci. 2018. “Alarm Anti‐Protease Trappin‐2 Negatively Correlates With Proinflammatory Cytokines in Patients With Periodontitis.” Journal of Periodontology 89: 58–66. https://doi.org/10.1902/jop.2017.170245.
-
- Afacan, B., V. O. Ozturk, G. Emingil, T. Kose, K. Mitsakakis, and N. Bostanci. 2022. “Salivary Secretory Leukocyte Protease Inhibitor Levels in Patients With Stage 3 Grade C Periodontitis: A Comparative Cross‐Sectional Study.” Scientific Reports 12: 21267. https://doi.org/10.1038/s41598‐022‐24295‐2.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
